# Cell Therapy Associated With Endobronchial Valve

> **NCT04018729** · PHASE2,PHASE3 · RECRUITING · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 34 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease Severe

## Interventions

- **DEVICE:** Zephyr Endobronchial Valve
- **BIOLOGICAL:** Marrow-derived mesenchymal stromal cell

## Key facts

- **NCT ID:** NCT04018729
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-11-19
- **Primary completion:** 2020-08-17
- **Final completion:** 2029-04-30
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2022-12-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04018729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04018729, "Cell Therapy Associated With Endobronchial Valve". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04018729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*